Ad is loading...
PGRRX
Price
$50.44
Change
+$0.68 (+1.37%)
Updated
Nov 22 closing price
PMAQX
Price
$48.96
Change
+$0.69 (+1.43%)
Updated
Nov 22 closing price
Ad is loading...

PGRRX vs PMAQX

Header iconPGRRX vs PMAQX Comparison
Open Charts PGRRX vs PMAQXBanner chart's image
Pioneer Select Mid Cap Growth R
Price$50.44
Change+$0.68 (+1.37%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$48.96
Change+$0.69 (+1.43%)
VolumeN/A
CapitalizationN/A
PGRRX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGRRX vs. PMAQX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGRRX is a Buy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.9B vs. PGRRX (1.59B). PMAQX pays higher dividends than PGRRX: PMAQX (0.10) vs PGRRX (0.00). PGRRX was incepted earlier than PMAQX: PGRRX (31 years) vs PMAQX (8 years). PGRRX is a more actively managed with annual turnover of: 72.00 vs. PMAQX (10.10). PGRRX (0) and PMAQX (0) have matching initial minimum investment requirements. PGRRX annual gain was more profitable for investors over the last year : 41.37 vs. PMAQX (30.40). PMAQX return over 5 years is better than : 54.74 vs. PGRRX (19.58).
PGRRXPMAQXPGRRX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years8 years-
Gain YTD30.10125.900116%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B29.9B5%
Annual Yield % from dividends0.000.10-
Returns for 1 year41.3730.40136%
Returns for 3 years-9.778.57-114%
Returns for 5 years19.5854.7436%
Returns for 10 years39.38N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CORT57.541.62
+2.90%
Corcept Therapeutics
XPEL45.730.88
+1.96%
XPEL
MCO480.663.59
+0.75%
Moody's Corp
ORGO4.050.03
+0.75%
Organogenesis Holdings
ELTX4.93-0.19
-3.71%
Elicio Therapeutics